SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057147
Filing Date
2023-11-01
Accepted
2023-11-01 08:40:29
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-20230930.htm   iXBRL 10-Q 3117980
2 EX-10.1 atra-ex10_1.htm EX-10.1 41148
3 EX-10.2 atra-ex10_2.htm EX-10.2 134862
4 EX-31.1 atra-ex31_1.htm EX-31.1 15285
5 EX-31.2 atra-ex31_2.htm EX-31.2 15180
6 EX-32.1 atra-ex32_1.htm EX-32.1 10867
  Complete submission text file 0000950170-23-057147.txt   10058635

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atra-20230930.xsd EX-101.SCH 71899
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atra-20230930_def.xml EX-101.DEF 196612
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atra-20230930_lab.xml EX-101.LAB 518866
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atra-20230930_cal.xml EX-101.CAL 68552
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atra-20230930_pre.xml EX-101.PRE 386727
69 EXTRACTED XBRL INSTANCE DOCUMENT atra-20230930_htm.xml XML 1627285
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 231366701
SIC: 2836 Biological Products, (No Diagnostic Substances)